SpringWorks Therapeutics, Inc.
(NASDAQ GS: SWTX)
Rigrodsky Law, P.A. is investigating SpringWorks Therapeutics, Inc. (“SpringWorks”) regarding possible breaches of fiduciary duties and other violations of law related to SpringWorks’ agreement to be acquired by Merck KGaA, Darmstadt, Germany. Under the terms of the agreement, SpringWorks shareholders will receive $47.00 per share in cash.